Nirmal Raut· @oncologician · X·· 3 天前评分70
正文 · 原文
Final OS analysis of sacituzumab tirumotecan (sac-TMT) versus platinum-based chemotherapy in EGFR-mutated non-small cell lung cancer (NSCLC) after progression on EGFR-TKI: Phase III OptiTROP-Lung04 study #ESMO2026
Wen Feng Fang (CN)
14 浏览 · 1 赞 · 0 转发 · 0 回复
来源：Nirmal Raut · x.com